Skip to main content
Premium Trial:

Request an Annual Quote

Weinstock Leaves Baylor for Wash U, Whitfield to Chair BioSeek Board, Rosetta Genomics Appoints Medical Advisors, and Others

NEW YORK (GenomeWeb News) - George Weinstock has joined Washington University in St. Louis as a professor of genetics, where he will also serve as associate director of the university’s Genome Sequencing Center, GenomeWeb Daily News sister publication In Sequence reported this week. He started his new appointment in January.
Weinstock comes to Wash U from Baylor College of Medicine, where he was a professor in the departments of molecular and human genetics and molecular virology and microbiology, and co-director of the Human Genome Sequencing Center. He holds a PhD in microbiology from the Massachusetts Institute of Technology and a BS in biophysics from the University of Michigan.

Roy Whitfield has been elected executive chairman of BioSeek’s board of directors. Whitfield joined the company’s board in 2005 and has also served as a business advisor to the firm.
Whitfield most recently served as CEO and chairman of Incyte, which he co-founded in 1991. He is still on the board of Incyte, and is also on the boards of Nektar Therapeutics, Illumina, and several private companies.
Whitfield received a BA degree from Oxford University and an MBA from Stanford University.

BioTrove has promoted Kevin Munnelly to vice president and general manager of its OpenArray division and Can "Jon" Ozbal to vice president and general manager of its RapidFire division.
Munnelly joined BioTrove in 2005 as manager of the OpenArray business unit and senior director in the genomics products division. Prior to BioTrove, he was senior manager of the platform technology group at Millennium Pharmaceuticals, and also served as a scientist with Applied Biosystems.
Ozbal has been with BioTrove since the company was founded. Prior to joining the firm, he was an instructor in the division of bioengineering and environmental health at the Massachusetts Institute of Technology.

Peter Covitz, chief operating officer for the National Cancer Institute’s Center for Bioinformatics, will leave the NCI at the end of February to join MDS Nordion as senior vice president of Innovation, a newly created position.
MDS Nordion is a provider of medical isotopes and radiopharmaceuticals based in Ottawa, Canada.
Covitz worked at the NCICB for six years and played an instrumental role in launching the Cancer Biomedical Informatics Grid project. Prior to joining the NCI, he was vice president of scientific collaborations at InforMax.
Covitz holds a Ph.D in microbiology from Columbia University and a BA with a major in biology from Colgate University.

Transgenomic has appointed David Pauluzzi to its board of directors. Pauluzzi is a consultant at Water Street Healthcare Partners, a Chicago-based private equity firm specializing in the healthcare sector.
Pauluzzi previously served as executive director and vice president of Quest Diagnostics, where he directed operations, marketing, and sales for the company’s esoteric anatomic pathology business and managed the sales and marketing organization for its hospital division. He also served as VP of sales and marketing and COO for US Labs, a national anatomic pathology reference laboratory.
He has also held sales and marketing positions at Ventana Medical Systems and Abbott Laboratories.

Rosetta Genomics this week announced the establishment of its medical advisory board.
Moshe Hod, a professor of obstetrics and gynecology at the Helen Schneider Hospital for Women at the Rabin Medical Center, Tel-Aviv University, will serve as chairman of the board.
Also joining the board are Harvey Pass, professor of cardiothoracic surgery and surgery at New York University School of Medicine; David Sidransky, a professor of oncology, otolaryngology, cellular and molecular medicine, urology, genetics, and pathology at Johns Hopkins University; Isaac Yaniv, chairman of the pediatric hematology oncology division at the Schneider Children's Medical Center; Jack Baniel, professor of urology at the Rabin Medical Center; Raphael Catane, a professor of oncology at the Chaim Sheba Medical Center, Tel Hashomer; and Maya Gottfried, a lung oncology researcher at the Meir Medical Center.

Authentication software firm BioPassword has appointed Matthew Shanahan as senior vice president of marketing and strategy. Shanahan most recently served as chief marketing officer for Teranode. Prior to that, he was a product manager at Documentum, where he spent 10 years before the company was acquired by EMC. Before that, Shanahan was a manager at Accenture specializing in advanced enterprise architectures for Global 500 companies.

Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in PEOPLE, a weekly roundup of industry comings and goings.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.